A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia

Laura M. Gault*, Craig W. Ritchie, Weining Z. Robieson, Yili Pritchett, Ahmed A. Othman, Robert A. Lenz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science